Australian semiconductor company Archer Materials (ASX: AXE) has progressed its latest Biochip design to the next phase of development by dispatching it to the VTT Technical Research Centre of Finland Ltd (VTT) for manufacturing. The Biochip’s newest graphene field-effect transistor (gFET) design, which was announced in July 2024, marks a milestone in enhancing it’s functionality,
Read More
Australian semiconductor company Archer Materials (ASX: AXE) has developed a novel graphene transistor test that will produce the most stable and accurate gFETs for future development activities and commercialisation of their biochip for the medical diagnostics industry. The new procedure, designed to scrutinise the gFET sensors under various conditions and electrical operation modes, was developed
Read More
Australian semiconductor company Archer Materials (ASX: AXE) is one step closer to the commercialisation of their graphene-based Biochip, a recent design of which has been successfully manufactured by foundry partner Graphenea in Spain, carving a pathway towards its future production. The milestone advances Archer’s Biochip capabilities in access to commercial semiconductor production facilities for technologies
Read More
Semiconductor company Archer Materials (ASX: AXE) has made notable technology development progress with its 12CQ quantum chip and its Biochip lab-on-a-chip technology. To progress the 12CQ chip development, Archer designed, developed and built a new type of device called a pulsed electron spin resonance (p-ESR) chip. Archer was able to leverage the expertise of Swiss-based
Read More
Working closer towards commercialising its cutting-edge graphene Biochip, semiconductor company Archer Materials (ASX: AXE) has dispatched its latest chip design iteration to a certified foundry in Spain for fabrication through a whole wafer manufacturing run. This move is part of Archer’s ongoing commitment to pushing the boundaries in both quantum computing and medical diagnostics while
Read More
A semiconductor company with a quantum computing and medical diagnostics focus, Archer Materials Limited (ASX: AXE), has announced a notable development in its advanced Biochip graphene field effect transistor (gFET) technology. Archer has successfully demonstrated multiplexing readout capabilities for its Biochip, i.e. they have shown the device can make sense of multiple liquid samples arriving
Read More